TARA-002
TARA-002-301
Phase 3 small_molecule active
Quick answer
TARA-002 for Bladder (Urothelial, Transitional Cell) Cancer is a Phase 3 program (small_molecule) at Protara Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Protara Therapeutics
- Indication
- Bladder (Urothelial, Transitional Cell) Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active